ATE314653T1 - Immunoassay für c-reaktives protein - Google Patents

Immunoassay für c-reaktives protein

Info

Publication number
ATE314653T1
ATE314653T1 AT01303068T AT01303068T ATE314653T1 AT E314653 T1 ATE314653 T1 AT E314653T1 AT 01303068 T AT01303068 T AT 01303068T AT 01303068 T AT01303068 T AT 01303068T AT E314653 T1 ATE314653 T1 AT E314653T1
Authority
AT
Austria
Prior art keywords
immunoassay
antibody
antiidiotypic
reactive protein
monoclonal antibody
Prior art date
Application number
AT01303068T
Other languages
English (en)
Inventor
Edward R Scalice
John L Daiss
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE314653T1 publication Critical patent/ATE314653T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01303068T 2000-03-31 2001-03-30 Immunoassay für c-reaktives protein ATE314653T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19395100P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
ATE314653T1 true ATE314653T1 (de) 2006-01-15

Family

ID=22715702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01303068T ATE314653T1 (de) 2000-03-31 2001-03-30 Immunoassay für c-reaktives protein

Country Status (8)

Country Link
US (1) US6838250B2 (de)
EP (1) EP1139101B1 (de)
JP (1) JP5031148B2 (de)
AT (1) ATE314653T1 (de)
DE (1) DE60116172T2 (de)
DK (1) DK1139101T3 (de)
ES (1) ES2254330T3 (de)
HK (1) HK1038069A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005031A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
JP4956705B2 (ja) * 2004-07-02 2012-06-20 株式会社三和化学研究所 免疫測定装置及び方法
KR20080006617A (ko) 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
US20060246522A1 (en) * 2005-04-28 2006-11-02 Bhullar Balwant S C-reactive protein immunoassay and method
JP5097557B2 (ja) * 2005-12-22 2012-12-12 ローム株式会社 免疫測定装置及び方法
US8383350B1 (en) 2006-12-20 2013-02-26 Merck Sharp & Dohme Corp. Assay for detection of IL-10 antibodies
CA2696210A1 (en) * 2007-08-28 2009-03-12 Abbott Biotechnology Ltd. Compositions and methods comprising binding proteins for adalimumab
JP4970217B2 (ja) * 2007-11-07 2012-07-04 株式会社東芝 物質の測定方法
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
JP5265257B2 (ja) * 2008-06-30 2013-08-14 富士フイルム株式会社 犬ｃｒｐ及び人ｃｒｐを認識する抗体
AU2009314259B2 (en) 2008-11-11 2015-06-11 Nestec S.A. Methods for prediction of inflammatory bowel disease (IBD) using serologic markers
WO2010058860A1 (ja) * 2008-11-18 2010-05-27 株式会社シノテスト 試料中のｃ反応性蛋白質の測定方法及び測定試薬
EP2419529B1 (de) 2009-04-14 2015-05-20 Nestec S.A. Prognostik entzündlicher darmerkrankung
JP5736370B2 (ja) 2009-06-25 2015-06-17 ネステク ソシエテ アノニム 過敏性腸症候群の診断方法
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
DK3789038T3 (da) 2010-05-14 2022-10-17 Univ Leland Stanford Junior Humaniserede og kimære monoklonale antistoffer mod cd47
EP2630495B1 (de) 2010-10-18 2017-02-08 Nestec S.A. Verfahren zur bestimmung von gegen medikamente gerichtete antikörperisotypen
KR20140008397A (ko) 2011-02-17 2014-01-21 네스텍 소시에테아노님 항-ＴＮＦα 약물에 대한 자가항체 검출을 위한 검정법
US20140065164A1 (en) 2011-04-29 2014-03-06 Bristol-Myers Squibb Company Ip-10 antibody dosage escalation regimens
CA2839792A1 (en) 2011-05-10 2012-11-15 Nestec S.A. Methods of disease activity profiling for personalized therapy management
SG11201401536QA (en) 2011-10-21 2014-05-29 Nestec Sa Methods for improving inflammatory bowel disease diagnosis
CA2861793C (en) 2011-12-28 2023-08-01 Immunoqure Ag Method of providing monoclonal auto-antibodies with desired specificity
AU2013326070A1 (en) 2012-10-05 2015-04-23 Société des Produits Nestlé S.A. Methods for predicting and monitoring mucosal healing
EP3004892B1 (de) 2013-05-24 2018-10-10 Nestec S.A. Methode zur diagnostizierung des reizdarmsyndroms
KR102402973B1 (ko) 2013-07-03 2022-05-27 이뮤노큐어 아게 인간 항-ifn-알파 항체
ES2654906T3 (es) 2013-11-05 2018-02-15 Roche Diagnostics Gmbh Método para determinar la cantidad total y/o la concentración de un analito en presencia de una molécula ligante, así como kits, composiciones y usos relacionados con el mismo
CA2932571A1 (en) 2013-12-03 2015-06-11 Nestec S.A. Methods for predicting post-operative recurrence of crohn's disease
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
WO2016088068A1 (en) 2014-12-02 2016-06-09 Nestec S.A. Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
WO2017079653A2 (en) 2015-11-06 2017-05-11 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
CN108279229B (zh) * 2017-01-05 2024-02-27 深圳市帝迈生物技术有限公司 一种全血crp检测装置
WO2019073391A1 (en) 2017-10-10 2019-04-18 Nestec S.A. METHODS OF MONITORING VEDOLIZUMAB TREATMENT
CN112051403A (zh) * 2020-08-27 2020-12-08 武汉生之源生物科技股份有限公司 C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
EP4357778A1 (de) 2022-10-20 2024-04-24 Heraeus Medical GmbH Behandlung von mikrobiellen infektionen mit diagnose durch biomarker d-lactat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) * 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
EP0210410B1 (de) * 1985-07-22 1992-05-20 Abbott Laboratories Fluoreszenz-Polarisation-Immunotest und Reagens zur Messung von C-reaktivem Protein
JPH04505857A (ja) 1989-06-27 1992-10-15 ラッシュ―プレズビティリアン―セント　ルークス　メディカル　センター Ｃ反応性蛋白質に対するモノクローナル抗体
JP3174402B2 (ja) * 1992-06-08 2001-06-11 三洋化成工業株式会社 競合法による免疫測定法および測定用キット
JPH10282098A (ja) * 1997-04-11 1998-10-23 Matsushita Electric Ind Co Ltd 蛍光免疫測定法

Also Published As

Publication number Publication date
EP1139101A2 (de) 2001-10-04
HK1038069A1 (en) 2002-03-01
EP1139101A9 (de) 2002-03-20
EP1139101B1 (de) 2005-12-28
JP5031148B2 (ja) 2012-09-19
US20020142356A1 (en) 2002-10-03
JP2002040024A (ja) 2002-02-06
DE60116172T2 (de) 2006-08-03
EP1139101A3 (de) 2002-05-15
US6838250B2 (en) 2005-01-04
ES2254330T3 (es) 2006-06-16
DE60116172D1 (de) 2006-02-02
DK1139101T3 (da) 2006-04-10

Similar Documents

Publication Publication Date Title
ATE314653T1 (de) Immunoassay für c-reaktives protein
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
HRP20030087B1 (en) Anti-il-12 antibodies, compositions, methods and uses
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
DE60334141D1 (de) VERÄNDERUNG VON FcRn-BINDUNGSAFFINITÄTEN ODER VON SERUMHALBWERTSZEITEN VON ANTIKÖRPERN MITTELS MUTAGENESE
ES2184660T1 (es) Anticuerpos humanizados que secuestran peptidos abeta.
WO2005026209A3 (en) Monoclonal antibodies against hmgb1
TW200516083A (en) Methods for making dual specificity antibodies
RS51197B (sr) Anti-dual integrinska antitela, sastavi, metode i njihove upotrebe
ATE474226T1 (de) Taxol-immunoassay
WO1998023955A3 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
WO2004025248A3 (en) Antibody pair screening methods
DE60224346D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
DE60222816D1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
ATE410693T1 (de) Hcv-test
EP1245957A3 (de) Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
WO2002076406A3 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
ES2126608T3 (es) Procedimiento para la determinacion de antigenos o anticuerpos en presencia de un inmunocomplejo.
AR023204A1 (es) Anticuerpos contra la proteina placentaria 13.
ATE336513T1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1139101

Country of ref document: EP

REN Ceased due to non-payment of the annual fee